The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • A R Krarup
  • M Abdel-Mohsen, The Wistar Institute, Philadelphia, Pennsylvania 19104-4268, USA, M H Schleimann,
  • L Vibholm
  • P A Engen, Division of Digestive Diseases and Nutrition, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.,
  • A Dige
  • B Wittig, Foundation Institute Molecular Biology and Bioinformatics, Freie Universitaet, Berlin, Germany.,
  • M Schmidt
  • S J Green, Department of Biological Sciences, University of Illinois at Chicago, Chicago, Illinois, USA., A Naqib, DNA Services Facility, Research Resources Center, University of Illinois at Chicago, Chicago, Illinois, USA., A Keshavarzian, Division of Digestive Diseases and Nutrition, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA., X Deng,
  • R Olesen
  • A M Petersen, Department of Microbiology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark., T Benfield, c Department of Infectious Diseases , Hvidovre Hospital , Hvidovre , Denmark.,
  • L Østergaard
  • T A Rasmussen
  • J Agnholt
  • J R Nyengaard
  • A Landay, Department of Immunology/Microbiology, Rush University Medical Center, Chicago, Illinois, USA.,
  • O S Søgaard
  • S K Pillai, Multiple Sclerosis Center, University of California San Francisco, CA, USA.,
  • M Tolstrup
  • P W Denton
OriginalsprogEngelsk
TidsskriftMucosal Immunology
Vol/bind11
Sider (fra-til)449–461
ISSN1933-0219
DOI
StatusUdgivet - 2018

Se relationer på Aarhus Universitet Citationsformater

ID: 116293070